First Weight-Loss Pill From Lilly Shows Promising Results

First Weight-Loss Pill From Lilly Shows Promising Results

Key Takeaways

Lilly Promises to Make Weight-Loss Pill in US in Reshoring Push

Eli Lilly & Co. plans to manufacture its new weight-loss pill in the US for patients around the world as President Donald Trump presses companies to move production back to American shores.

A very good day for Lilly, and a bad day for Novo

Today's biotech news includes a second chance for GSK’s multiple myeloma drug, Sanofi's bet on a mysterious AI startup, and more.

Daily weight-loss pill could be as effective as injectables

The NewsEli Lilly’s share price soared after it said a daily weight-loss pill showed similar results to injectable drugs Ozempic and Mounjaro. Orforglipron helped patients lose an average 7.9% of their body weight in 40 weeks in clinical trials, compared with the 1.6% weight lost by those taking a placebo. The drug was less successful at reducing blood sugar, and at high doses about a quarter of patients experienced nausea, vomiting, or diarrhea…

New pills doing the trick? Eli Lilly’s oral weight-loss drug sparks stock rally

Eli Lilly stocks displayed a major rise after the announcement of a new oral weight-loss drug that has put pressure on its rival pharmaceutical companies

Eli Lilly shares surge on new obesity pill data. What it means for the stock from here

Jim Cramer said Eli Lilly's new trial data has turned the obesity market into a 'one-horse race.'